Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD-1433 kills various viruses within seconds

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jul 12, 2022 11:14am

296 Views

Post# 34818031

RE:RE:RE:RE:RE:RE:TLD-1433 kills various viruses within seconds

Oilminerdeluxe wrote
Man, I yearn to know about how the next 270 and 360 day data looks like. A sharp increase in CR and everything could change just like that.

Perhaps I can add to your excitement Oilminerdeluxe!

Looking at my patient chart it appears patients 21 to 24 will be hitting their 270 day at the end of June/2022 interestingly patient 25 might hit 270 somewhere in the first half of July so that unfortunately put him/her into 3rdQ.

Patients 17 to 20 will be celebrating their 360 for our next update

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth